These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28402681)

  • 21. Assessment of new triplet forming artificial nucleobases as RNA ligands directed towards HCV IRES IIId loop.
    Safir Filho M; Martin AR; Benhida R
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1780-1783. PubMed ID: 28274634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of translation by the 5'- and 3'-terminal regions of the dengue virus genome.
    Chiu WW; Kinney RM; Dreher TW
    J Virol; 2005 Jul; 79(13):8303-15. PubMed ID: 15956576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of dengue virus cyclization sequences located at the 5' and 3'UTRs.
    Alvarez DE; Filomatori CV; Gamarnik AV
    Virology; 2008 May; 375(1):223-35. PubMed ID: 18289628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
    Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
    J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of infectivity of porcine circovirus type 2 (PCV2) by capsid-binding 2'F-RNA aptamers.
    Yoon S; Lee G; Han D; Song JY; Kang KS; Lee YS
    Antiviral Res; 2010 Oct; 88(1):19-24. PubMed ID: 20615431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
    Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absolute quantification of cell-bound DNA aptamers during SELEX.
    Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
    Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target replacement strategy for selection of DNA aptamers against the Fc region of mouse IgG.
    Ma J; Wang MG; Mao AH; Zeng JY; Liu YQ; Wang XQ; Ma J; Tian YJ; Ma N; Yang N; Wang L; Liao SQ
    Genet Mol Res; 2013 Apr; 12(2):1399-410. PubMed ID: 23661463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput screening using dengue virus reporter genomes.
    Fischl W; Bartenschlager R
    Methods Mol Biol; 2013; 1030():205-19. PubMed ID: 23821271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue Virus Inhibition Targets: A Review and Docking Study.
    Scotti L; Scotti MT; Yarla NS; Monteiro AFM; de Oliveira Viana J; Dantzger DRC; Ishiki HM
    Curr Top Med Chem; 2018; 18(18):1522-1530. PubMed ID: 30360718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection and versatile application of virus-specific aptamers.
    Balogh Z; Lautner G; Bardóczy V; Komorowska B; Gyurcsányi RE; Mészáros T
    FASEB J; 2010 Nov; 24(11):4187-95. PubMed ID: 20624933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aptamers targeting rabies virus-infected cells inhibit street rabies virus in vivo.
    Liang HR; Hu GQ; Li L; Gao YW; Yang ST; Xia XZ
    Int Immunopharmacol; 2014 Aug; 21(2):432-8. PubMed ID: 24735817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for the treatment of dengue virus infections: a narrative account.
    De Clercq E
    Future Med Chem; 2010 Apr; 2(4):601-8. PubMed ID: 21426010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of aptamers as specific binders and modulators of cell-surface receptor activity.
    Ulrich H; Wrenger C
    Methods Mol Biol; 2013; 986():17-39. PubMed ID: 23436403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Medicinal Chemistry of Dengue Virus.
    Behnam MA; Nitsche C; Boldescu V; Klein CD
    J Med Chem; 2016 Jun; 59(12):5622-49. PubMed ID: 26771861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. True Blood: dengue virus evolution.
    Wash R; Soria CD
    Nat Rev Microbiol; 2015 Nov; 13(11):662. PubMed ID: 26439086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The screening of RNA aptamers specific for carbonic anhydrase I using the Systematic Evolution of Ligands by an Exponential Enrichment Method (SELEX).
    Shrivastava G; Hyodo M; Ara MN; Harashima H
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(11):697-708. PubMed ID: 25295747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamers: a new class of oligonucleotides in the drug discovery pipeline?
    Dausse E; Da Rocha Gomes S; Toulmé JJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):602-7. PubMed ID: 19717337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilization of dengue virus polymerase in de novo initiation assay provides advantages for compound screening.
    Niyomrattanakit P; Wan KF; Chung KY; Abas SN; Seh CC; Dong H; Lim CC; Chao AT; Lee CB; Nilar S; Lescar J; Shi PY; Beer D; Lim SP
    Antiviral Res; 2015 Jul; 119():36-46. PubMed ID: 25896272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.